Oruka Therapeutics, Inc. is a biotechnology company, which focuses on developing novel monoclonal antibody therapeutics for PsO and other I&I indications. Its pipeline includes ORKA-001 and ORKA-002.
Oruka Therapeutics stock last closed at $9.30, up 0.87% from the previous day, and has decreased 77.54% in one year. It has overperformed other stocks in the Biotechnology industry by 0 percentage points. Oruka Therapeutics stock is currently +69.55% from its 52-week low of $5.49, and -82.74% from its 52-week high of $53.88.
At the moment, there are 37.44M ORKA shares outstanding. The market capitalization of ORKA is $348.20M. In the past 24 hours, 309,802 ORKA shares were traded.
How to Buy Oruka Therapeutics Stock
Wondering how to invest in Oruka Therapeutics stock? Here's how.
Decide where to buy Oruka Therapeutics stock: You need to choose a stock brokerage, but don't worry - we've analyzed dozens of stock brokerages and apps to help you decide where to buy Oruka Therapeutics stock.
Open a brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've selected.
Deposit money your investment account: Choose your payment method and add your details.
Analyze Oruka Therapeutics stock: The Oruka Therapeutics ticker symbol is ORKA. Is Oruka Therapeutics stock a good investment? Should you buy shares of ORKA? How do ORKA's underlying business fundamentals look? Do top analysts think Oruka Therapeutics is a good buy? Why has ORKA's stock price moved recently? (Hint: Our stock market research tools can help you understand if ORKA is a good stock to buy).
Make your ORKA trade: Decide if you will purchase ORKA shares at the current market price or use a limit order to buy ORKA stock at a given price.
Track your ORKA investment: Create a watchlist to keep track of your new investment in Oruka Therapeutics shares.
Step 1: Decide where to buy Oruka Therapeutics stock
You will need a brokerage account in order to access the NASDAQ market and buy ORKA stock.
A brokerage account is an investment account that enables you to buy and sell a variety of investments, including stocks, bonds, mutual funds, and ETFs.
Our favorite brokerage: eToro
We believe that eToro is the best stock brokerage. eToro gives you:
You can invest in stocks with zero commissions: Invest without paying trading commissions.
Buy fractional shares: Even if you can't afford a full share, you can still buy the stock.
Access to world financial markets: From Tech to Healthcare, New York to Shanghai (for US users, only US stocks are available) — you can fill your portfolio with stocks from the globe's leading stock exchanges.
Social investing: eToro boasts a community of more than 20 million users globally. Talk to, learn from, and copy the crypto trades of top investors.
Security: eToro is a regulated and licensed fintech leader.
Buy other financial assets: Such as ETFs and cryptos.
Get $10 towards your purchase of shares by opening an account with eToro today. This offer is only for US users.
eToro securities trading is offered by eToro USA Securities, Inc. (“the BD”), member of FINRA and SIPC. Cryptocurrency is offered by eToro USA LLC (“the MSB”) (NMLS: 1769299) and is not FDIC or SIPC insured. Investing involves risk, and content is provided for educational purposes only, does not imply a recommendation, and is not a guarantee of future performance. https://www.wallstreetzen.com is not an affiliate and may be compensated if you access certain products or services offered by the MSB and/or the BD.
Step 2: Open a brokerage account
Now that you've selected the right brokerage, it's time to fill out some personal details so you are able to invest in ORKA stock today.
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
Step 4: Analyze Oruka Therapeutics stock
Once you have selected the best place to buy Oruka Therapeutics stock, it's crucial to analyze their stock before you buy, so you can wrap your head around the risk as well as the upside.
Overview of key ORKA info
ORKA Price
$9.30
1w %
14.25%
1y %
-77.54%
5y %
-80.53%
P/E
-2.4x
P/B
0.91x
P/S
N/A
PEG
N/A
Revenue
$0.00
Earnings
-$83.72M
Fore. Rev. Growth
N/A
Fore. Earn. Growth
N/A
Market Cap
$348.20M
Next Earnings
Apr 23, 2025
Next Dividend
N/A
Oruka Therapeutics Fundamentals
WallStreetZen was designed to help everyday investors perform more in-depth fundamental analysis in less time.
In the past 12 months, insiders at ORKA have bought more shares than they have sold.
Venrock Healthcare Capital Partners III LP, 10% Owner of ORKA, was the latest ORKA insider to buy. They bought $1,015,803.36 worth of ORKA shares on Feb 14, 2025.
No, Oruka Therapeutics doesn't provide an income stream by paying out dividends.
ORKA Social Trading Data
One of the major reasons eToro is our favorite brokerage is because of its social trading community.
Click below to see what other traders have to say.
Step 5: Make your ORKA trade
There are two primary order types:
Market order: A market order is an order to buy or sell a stock at the best price on the market. Market orders are mostly fine for most investors.
Limit order: A limit order enables you to buy or sell a security at a specific price (or better). If you want to be sure you're buying or selling at a given price, place a limit order.
Click the Open Trade button and your broker will execute your order.
If you require more info about investing in stocks on eToro, watch the how to video below:
How much does it cost to buy one Oruka Therapeutics share?
As of Apr 21, 2025, it costs $9.30 to buy one share of Oruka Therapeutics stock.
Remember, eToro's fractional share buying allows you to buy partial shares of stocks and ETFs. Even if you only have $4, you can buy 0.43 shares of ORKA.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.